SS-31 (Elamipretide) is listed in the Research Peptides catalog with 4 matched SKU/form rows: 10 / Injectable, 20 / Injectable, 25 / Injectable, plus 1 more. The lowest published tier starts at $4.08. The table is a procurement reference, not a dosing instruction. The quotation confirms the exact supplied identity, specification, allocated lot, available batch documents, handling and destination-specific delivery terms. The clinical references below are research context, not evidence about this catalog lot. This listing is for research procurement only.
| Catalog identity | SS-31 (Elamipretide) |
| Catalog category | Research Peptides |
| Price-list identity | SS-31 (Elamipretide) |
| SKU / form rows | 10 / Injectable; 20 / Injectable; 25 / Injectable; 5 / Injectable |
| Research context | Clinical elamipretide studies in defined populations and endpoints; compare the study material and scope with the offered lot. |
| Specification and purity | Confirm the offered specification, method, acceptance criterion and allocated-lot result in the quotation. No sitewide purity guarantee is made. |
| Documents and handling | Confirm available batch documents, storage, packaging, transit conditions and destination requirements for the exact supplied form. |
Wholesale from $4.08
Price-list tiers apply when the order reaches 100+ total units. Each tier is based on the quantity of the individual SKU; smaller orders are quoted separately.
| SKU / form | 10–24 units of this SKU | 25–49 units of this SKU | 50+ units of this SKU |
|---|---|---|---|
| 10 / Injectable | $8.00 | $7.00 | $6.00 |
| 20 / Injectable | $16.32 | $14.28 | $12.24 |
| 25 / Injectable | $19.04 | $16.66 | $14.28 |
| 5 / Injectable | $5.44 | $4.76 | $4.08 |
The labels above reproduce the current price-list entries. They are not dosage instructions. Confirm the unit, exact supplied form, allocated lot, analytical package and availability in the quote.
Karaa et al. (2018), "Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy". This randomized dose-escalation study reports observations in adults with a defined mitochondrial-myopathy population. DOI 10.1212/WNL.0000000000005255 PMID 29500292
Daubert et al. (2020), "Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial". This Phase 2 paper reports its stated cardiac endpoint in a defined patient population. DOI 10.1016/j.cardfail.2020.02.001 PMID 32068002
Daubert et al. (2017), "Novel Mitochondria-Targeting Peptide in Heart Failure Treatment". This paper is included as additional research context for the named compound and study setting. DOI 10.1161/circheartfailure.117.004389 PMID 29217757
Evidence boundary: these publications do not identify the supplier, allocated lot, composition, purity, storage history or SKU. They are not dosing, administration, treatment, safety or efficacy instructions. Compare the study material and scope with the quote-specific identity and batch documents before relying on the context.
SS-31 (Elamipretide) is a research peptides catalog listing. Confirm the exact manufacturer, composition or sequence, supplied form and allocated-lot identity in the quotation.
The table shows the current published tiers for 4 matched SKU/form rows. The quote still confirms the allocated lot, availability, currency, destination terms and any rows that are price-on-request.
A purity figure is meaningful only when the method, acceptance criterion and allocated-lot result are identified. The quotation confirms what documentation is available; this page makes no universal purity guarantee.
Request the product identity and supplied form, specification, method and acceptance criteria, allocated-lot results, available COA or analytical documents, storage/handling instructions and destination-specific delivery terms.
The cited papers report elamipretide/SS-31 observations in defined clinical populations and endpoints. They do not identify the supplier, allocated lot, composition, purity or SKU, and they do not establish suitability, safety, efficacy or dosing for catalog material.
This catalog is for research procurement. It does not provide medical, veterinary, dosing, administration or treatment instructions. Check the laws and institutional requirements that apply to the intended work.
Wholesale from $1.80; confirm SKU, allocated lot and available batch documents in the quote.
View Details Research PeptidesWholesale from $1.80; confirm SKU, allocated lot and available batch documents in the quote.
View Details Research PeptidesWholesale from $1.80; confirm SKU, allocated lot and available batch documents in the quote.
View Details Research PeptidesWholesale from $1.53; confirm SKU, allocated lot and available batch documents in the quote.
View Details